External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study
- 4 January 2012
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 27 (1) , 47-52
Abstract
Recently, prediction models for type 2 diabetes mellitus (T2DM) in older adults (aged ≥55 year) were developed in the KORA S4/F4 study, Augsburg, Germany. We aimed to externally validate the KORA models in a Dutch population. We used data on both older adults (n = 2,050; aged ≥55 year) and total non-diabetic population (n = 6,317; aged 28–75 year) for this validation. We assessed performance of base model (model 1: age, sex, BMI, smoking, parental diabetes and hypertension) and two clinical models: model 1 plus fasting glucose (model 2); and model 2 plus uric acid (model 3). For 7-year risk of T2DM, we calculated C-statistic, Hosmer–Lemeshow χ2-statistic, and integrated discrimination improvement (IDI) as measures of discrimination, calibration and reclassification, respectively. After a median follow-up of 7.7 years, 199 (9.7%) and 374 (5.9%) incident cases of T2DM were ascertained in the older and total population, respectively. In the older adults, C-statistic was 0.66 for model 1. This was improved for model 2 and model 3 (C-statistic = 0.81) with significant IDI. In the total population, these respective C-statistics were 0.77, 0.85 and 0.85. All models showed poor calibration (P < 0.001). After adjustment for the intercept and slope of each model, we observed good calibration for most models in both older and total populations. We validated the KORA clinical models for prediction of T2DM in an older Dutch population, with discrimination similar to the development cohort. However, the models need to be corrected for intercept and slope to acquire good calibration for application in a different setting.Keywords
This publication has 23 references indexed in Scilit:
- Risk models and scores for type 2 diabetes: systematic reviewBMJ, 2011
- Plasma procalcitonin and risk of type 2 diabetes in the general populationDiabetologia, 2011
- Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 DiabetesEpidemiologic Reviews, 2011
- External Validity of Risk Models: Use of Benchmark Values to Disentangle a Case-Mix Effect From Incorrect CoefficientsAmerican Journal of Epidemiology, 2010
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- Population ageing research: a family of disciplinesEuropean Journal of Epidemiology, 2009
- Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and MortalityAmerican Journal of Epidemiology, 2008
- Identifying Individuals at High Risk for DiabetesDiabetes Care, 2005
- Global Prevalence of DiabetesDiabetes Care, 2004
- The Diabetes Risk ScoreDiabetes Care, 2003